Overview: Alternaria Racemosus Specific IgG TestIntroduction: The Alternaria Racemosus Specific IgG Test detects IgG antibodies to Alternaria racemosus mold, indicating exposure that may cause respiratory or allergic symptoms. Aligned with 2023 AAAAI guidelines, it uses an immunoassay for high sensitivity, aiding in allergy screening. This test is critical for guiding environmental management, treatment plans, and improving outcomes in immunology, particularly for patients with mold-related symptoms.
Other Names: Alternaria Racemosus IgG Assay, Alternaria Racemosus Antibody Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Mold allergy testing began in the 1960s with skin tests. Specific IgG immunoassays emerged in the 1980s, and by the 2000s, advanced assays improved specificity for fungal allergens like Alternaria racemosus.
Purpose: Diagnoses mold exposure, guides environmental management, and monitors allergic responses in patients with respiratory or allergic symptoms.
Test Parameters: 1. Alternaria Racemosus IgG
Pretest Condition: No fasting required. Collect serum or saliva at any time, ideally after recent mold exposure or symptom onset. Report symptoms like wheezing or nasal congestion, and list medications like antihistamines or corticosteroids.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document respiratory or allergic symptoms, mold exposure history, or family history of allergies. Include current medications, especially antihistamines or corticosteroids.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for environmental changes or treatment.
Procedural Considerations: Uses an immunoassay to measure Alternaria racemosus-specific IgG. Results are available in 3-5 days, supporting clinical decisions.
Factors Affecting Result Accuracy: Recent infections or immunosuppressive drugs may alter IgG levels. Hemolysis or improper storage can degrade samples. Cross-reactivity with other molds may affect specificity.
Clinical Significance: Elevated IgG levels indicate mold exposure, prompting environmental remediation or treatment. Normal levels may require IgE testing for allergic sensitivity.
Specialist Consultation: Consult an allergist or pulmonologist for result interpretation. An environmental health specialist referral is advised for mold remediation.
Additional Supporting Tests: Alternaria IgE test, skin prick test, or mold panel to confirm allergic sensitivity or identify other mold exposures.
Test Limitations: IgG levels indicate exposure, not necessarily allergy. Cross-reactivity with other molds requires clinical correlation.
References: AAAAI Allergy Guidelines, 2023; Clinical and Translational Allergy, Denning DW, 2022.
